Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPULSE: Cerebrolysin + atDCS for Stroke Recovery
NCT04124367Phase 2Terminated
- Sponsor
- EVER Pharma
- Start
- Jun 2021
- Primary completion
- Mar 2022
- Modality
- Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of cerebrolysin in ischemic stroke, sponsored by EVER Pharma. Started Jun 2021; status: terminated.
02
Drugs
cerebrolysin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04124367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04124367.